1,960 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 763 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9891,960 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,960
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1876
$194K
1877
$191K
1878
$189K
1879
$188K
1880
$176K
1881
$175K
1882
$172K
1883
$170K
1884
$169K
1885
$164K
1886
$161K
1887
$156K
1888
$155K
1889
$155K
1890
$153K
1891
$152K
1892
$150K
1893
$139K
1894
$131K
1895
$129K
1896
$129K
1897
$126K
1898
$124K
1899
$119K
1900
$116K